These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32348623)

  • 1. Thrombospondin-5 and fluvastatin promote angiogenesis and are protective against endothelial cell apoptosis.
    Muqri F; Helkin A; Maier KG; Gahtan V
    J Cell Biochem; 2020 Oct; 121(10):4154-4165. PubMed ID: 32348623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology.
    Helkin A; Maier KG; Gahtan V
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1022-1027. PubMed ID: 26168731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvastatin inhibits intimal hyperplasia in wild-type but not Thbs1-null mice.
    Desai P; Helkin A; Odugbesi A; Stein J; Bruch D; Lawler J; Maier KG; Gahtan V
    J Surg Res; 2017 Apr; 210():1-7. PubMed ID: 28457315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of differentiation/DNA binding proteins Id1 and Id3 are regulated by statins in endothelial cells.
    Pammer J; Reinisch C; Kaun C; Tschachler E; Wojta J
    Endothelium; 2004; 11(3-4):175-80. PubMed ID: 15370294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD36-TSP-HRGP interactions in the regulation of angiogenesis.
    Silverstein RL; Febbraio M
    Curr Pharm Des; 2007; 13(35):3559-67. PubMed ID: 18220792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin-1-induced apoptosis of brain microvascular endothelial cells can be mediated by TNF-R1.
    Rege TA; Stewart J; Dranka B; Benveniste EN; Silverstein RL; Gladson CL
    J Cell Physiol; 2009 Jan; 218(1):94-103. PubMed ID: 18726995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proangiogenic Properties of Thrombospondin-4.
    Muppala S; Frolova E; Xiao R; Krukovets I; Yoon S; Hoppe G; Vasanji A; Plow E; Stenina-Adognravi O
    Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):1975-86. PubMed ID: 26139464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
    Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
    Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.
    Tan BK; Adya R; Chen J; Farhatullah S; Heutling D; Mitchell D; Lehnert H; Randeva HS
    Cardiovasc Res; 2009 Aug; 83(3):566-74. PubMed ID: 19414528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis.
    Esser JS; Rahner S; Deckler M; Bode C; Patterson C; Moser M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):358-67. PubMed ID: 25503991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondins Differentially Regulate Proteins Involved in Arterial Remodeling.
    Kassem MM; Helkin A; Maier KG; Gahtan V
    Physiol Res; 2019 Dec; 68(6):893-900. PubMed ID: 31647293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels.
    Shao H; Tan Y; Eton D; Yang Z; Uberti MG; Li S; Schulick A; Yu H
    Stem Cells; 2008 May; 26(5):1376-84. PubMed ID: 18308946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway.
    Bussolati B; Assenzio B; Deregibus MC; Camussi G
    J Mol Med (Berl); 2006 Oct; 84(10):852-63. PubMed ID: 16924472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
    Noh YH; Matsuda K; Hong YK; Kunstfeld R; Riccardi L; Koch M; Oura H; Dadras SS; Streit M; Detmar M
    J Invest Dermatol; 2003 Dec; 121(6):1536-43. PubMed ID: 14675207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin reduces oxidative damage in human vascular endothelial cells by upregulating Bcl-2.
    Xu SZ; Zhong W; Watson NM; Dickerson E; Wake JD; Lindow SW; Newton CJ; Atkin SL
    J Thromb Haemost; 2008 Apr; 6(4):692-700. PubMed ID: 18221360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling.
    Anderson CR; Hastings NE; Blackman BR; Price RJ
    Am J Pathol; 2008 Oct; 173(4):1220-8. PubMed ID: 18772338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombospondin-1 modulates the angiogenic phenotype of human cerebral arteriovenous malformation endothelial cells.
    Stapleton CJ; Armstrong DL; Zidovetzki R; Liu CY; Giannotta SL; Hofman FM
    Neurosurgery; 2011 May; 68(5):1342-53; discussion 1353. PubMed ID: 21307796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin affects several angiogenic mediators in human endothelial cells.
    Dulak J; Loboda A; Jazwa A; Zagorska A; Dörler J; Alber H; Dichtl W; Weidinger F; Frick M; Jozkowicz A
    Endothelium; 2005; 12(5-6):233-41. PubMed ID: 16410222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombospondin-based antiangiogenic therapy.
    Zhang X; Lawler J
    Microvasc Res; 2007; 74(2-3):90-9. PubMed ID: 17559888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin-1 inhibits angiogenesis and promotes follicular atresia in a novel in vitro angiogenesis assay.
    Garside SA; Harlow CR; Hillier SG; Fraser HM; Thomas FH
    Endocrinology; 2010 Mar; 151(3):1280-9. PubMed ID: 20080874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.